Daisuke Takahari

16PUBLICATIONS
40CO-AUTHORS
Cancer geneticsPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 15, 2026
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer.

Takeru Wakatsuki, Noriko Yamamoto, Naoki Ishizuka

|Dec 14, 2024
Clinicopathological and prognostic significance of HER2-low expression in advanced gastric cancer: a retrospective observational study.

Yukiya Narita, Taro Mizuno, Yasunobu Ishizuka

|Jul 27, 2024
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study.

Koshiro Fukuda, Hiroki Osumi, Yuri Yoshinami

|Nov 06, 2023
Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A Single-Institution Retrospective Study.

Keitaro Shimozaki, Izuma Nakayama, Daisuke Takahari

|Jul 27, 2023
Perioperative immune checkpoint inhibitor therapy for gastric and gastroesophageal junction cancers: a review of current approaches and future perspectives.

Daisuke Takahari, Izuma Nakayama

|Jul 06, 2023
Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors.

Koshiro Fukuda, Hiroki Osumi, Koichiro Yoshino

Pageof 3

Frequent Collaborators

5 joint publications

Izuma Nakayama

4 joint publications

Mariko Ogura

4 joint publications

Kensei Yamaguchi

4 joint publications

Takeru Wakatsuki